Create a narrative

IOL Chemicals and Pharmaceuticals Community

BSE:524164 Community

1 Narratives written by author
0 Comments on narratives written by author
10 Fair Values set on narratives written by author

IOL Chemicals and Pharmaceuticals

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

New Facilities And Capacity Expansions Will Meet Rising Demand In Specialty Chemicals

Key Takeaways Strategic market expansion and onboarding new clients could drive substantial growth in the non-ibuprofen segment. Investments in new facilities and increased export efforts may enhance revenue and profitability through operational efficiencies.

₹90.00

FV

0.3% overvalued

11.39%

Revenue growth p.a.

0

0

6

3 days ago